Angioscopic predictors of early adverse outcome after coronary angioplasty in patients with unstable angina and non-Q-wave myocardial infarction

Circulation

Volumn 93, Issue 12, 1996, Pages 2106-2113

  Waxman, Sergio ^b   Sassower, Michael A ^b   Mittleman, Murray A ^b   Zarich, Stuart ^b   Miyamoto, Akira ^b   Manzo, Karen S ^b   Muller, James E ^b   Abela, George S ^b   Nesto, Richard W ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b NONE

Author keywords

angioplasty; angioscopy; coronary disease; prognosis; thrombus

Indexed keywords

ACUTE HEART INFARCTION; ANGIOSCOPY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY THROMBOSIS; DISEASE COURSE; FEMALE; HUMAN; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

EID: 0029938354     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.12.2106     Document Type: Article

References (58)

1. de Feyter PJ. Coronary angioplasty in unstable angina. Am Heart J. 1989;118:860-868.
2. Myler RK, Shaw RE, Stertzer SH, Hecht HS, Ryan C, Rosenblum J, Cumberland DC, Murphy MC, Hansell HN, Hidalgo B. Unstable angina and coronary angioplasty. Circulation. 1990;82:88-95.
3. de Feyter PJ, Suryapranata H, Serruys PW, Beatt K, van Domburg R, van den Brand M, Tijssen JJ, Azar AJ, Hugenholtz PG. Coronary angioplasty for unstable angina: immediate and late results in 200 consecutive patients with identification of risk factors for unfavorable early and late outcome. J Am Coll Cardiol. 1988;12:324-333.
4. Ellis SG, Vandormael MG, Cowley MJ, Disciascio G, Deligonul U, Topol EJ, Bulle TM. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: implications for patient selection. Circulation. 1990;82:1193-1202.
5. Ellis SG, Roubin GS, King SB III, Douglas JS Jr, Weintraub WS, Thomas RG, Cox WR. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation. 1988;77:372-379.
6. Kern MJ, Deligonul U, Galan K, Zelamn R, Gabliani G, Bell ST, Bodet J, Naunheim K, Vandormael M. Percutaneous transluminal coronary angioplasty in octogenarians. Am J Cardiol. 1988;61: 457-458.
7. Buffet P, Danchin N, Juilliere Y, Feldmann L, Marie PY, Selton-Suty C, Anconina J, Cherrier F. Percutaneous transluminal coronary angioplasty in patients more than 75 years old: early and long-term results. Int J Cardiol. 1992;37:33-39.
8. Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB, Loop FD, Peterson KL, Reeves TJ, Williams DO, Winters WL. Guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol. 1988;12:529-545.
9. Hermans WRM, Foley DP, Rensing BJ, Rutsch W, Heyndrickx GR, Danchin N, Mast G, Hanet C, Rablanche JM, Raflenbeul W, Uebis R, Balcon R, de Feyter PJ, Serruys PW, on behalf of the CARPORT and MERCATOR Study Group. Usefulness of quantitative and qualitative angiographic lesion morphology and clinical characteristics in predicting major adverse cardiac events during and after native coronary balloon angioplasty. Am J Cardiol. 1993; 72:14-20.
10. Detre KM, Holmes DR Jr, Holubkov R, Cowley MJ, Baurassa MG, Faxon DP, Dorros GR, Bentivoglio LG, Kent KM, Myler RK, and coinvestigators of the National Heart, Lung, and Blood Institute's Percutaneous Transluminal Coronary Angioplasty Registry. Incidence and consequences of periprocedural occlusion of the 1985-1986 National Heart, Lung, and Blood Institute's Percutaneous Transluminal Coronary Angioplasty Registry. Circulation. 1990; 82:739-750.
11. Myler RK, Shaw RE, Stertzer SH, Bashour TT, Ryan C, Hecht HS, Cumberland DC. Lesion morphology and coronary angioplasty: current experience and analysis. J Am Coll Cardiol. 1992;19: 1641-1652.
12. Mabin TA, Holmes DR Jr, Smith HC, Vlietstra RE, Bove AA, Reeder GS, Chesebro JH, Bresnahan JF, Orszulak TA. Intracoronary thrombus: role in coronary occlusion complicating percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1985;3: 198-202.
13. Sugrue DD, Holmes DR Jr, Smith HC, Reeder GS, Lane GE, Vlietstra RE, Bresnahan JF, Hammes LN, Piehler JM. Coronary artery thrombus as a risk factor for acute vessel occlusion during percutaneous transluminal coronary angioplasty: improving results. Br Heart J. 1986;56:62-66.
14. Deligonul U, Gabliani GI, Caralis DG, Kern MJ, Vandormael MG. Percutaneous transluminal coronary angioplasty in patients with intracoronary thrombus. Am J Cardiol. 1988;62:474-476.
15. den Heijer P, Foley DP, Escaned J, Hillege HL, van Dijk RB, Serruys PW, Lie KI. Angioscopic versus angiographic detection of intimai dissection and intracoronary thrombus. J Am Coll Cardiol. 1994;24:649-654.
16. Mizuno K, Satomura K, Miyamoto A, Arakawa K, Shibuya T, Arai T, Kurita A, Nakamura H, Ambrose JA. Angioscopic evaluation of coronary-artery thrombi in acute coronary syndromes. N Engl J Med. 1992;326:287-291.
17. Ramee SR, White CJ, Collins TJ, Mesa JE, Murgo JP. Percutaneous angioscopy during coronary angioplasty using a steerablc microangioscope. J Am Coll Cardiol. 1991;17:100-105.
18. White CJ, Ramee SR, Collins TJ, Mesa JE, Jain A. Percutaneous angioscopy of saphenous vein coronary bypass grafts. J Am Coll Cardiol. 1993;21:1181-1185.
19. The TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Circulation. 1994;89:1545-1556.
20. Sassower MA, Abela GS, Koch JM, Manzo KM, Friedl SE, Vivino PG, Nesto RW. Angioscopic evaluation of periprocedural abrupt closure after percutaneous coronary angioplasty. Am Heart J. 1993; 126:444-450.
21. Den Heijer P, van Dijk R, Hillege HL, Pentinga ML, Serruys PW, Lie KI. Serial angioscopic and angiographic observations during the first hour after successful coronary angioplasty: a preamble to a multicenter trial addressing angioscopic markers of restenosis. Am Heart J. 1994;128:656-663.
22. Ambrose JA, Winters SL, Arora RR, Haft JI, Goldstein J, Rentrop KP, Gorlin R, Fuster V. Coronary angiographic morphology in myocardial infarction: a link between the pathogenesis of unstable angina and myocardial infarction. J Am Coll Cardiol. 1985;6: 1233-1238.
23. Levin DC, Fallon JT. Significance of the angiographic morphology of localized coronary stenoses: histopathologic correlations. Circulation. 1982;66:316-320.
24. The TIMI IIIA Investigators. Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Circulation. 1993;87:38-52.
25. Den Heijer P, Foley DP, Hillege H, Lablanche JM, van Dijk RB, Franzen D, Morice MC, Serra A, De Scheerder I, Serruys PW, Lie KI. The 'Ermenonville' classification of observations at coronary angioscopy: evaluation of intra- and inter-observer agreement. Eur Heart J. 1994;15:815-822.
26. Waller BF, Gorfinkel HJ, Rogers FJ, Kent KM, Roberts WC. Early and late morphologic changes in major epicardial coronary arteries after percutaneous transluminal coronary angioplasty. Am J Cardiol. 1984;33:42C-47C.
27. Waller BF. Crackers, breakers, stretchers, drillers, scrapers, shavers, burners, welders and melters: the future treatment of atherosclerotic coronary artery disease? A clinical-morphologic assessment. J Am Coll Cardiol. 1989;13:969-987.
28. Block PC, Myler RK, Stertzer S, Fallon JT. Morphology after transluminal angioplasty in human beings. N Engl J Med. 1981;305: 382-385.
29. Fischell TA, Derby G, Tse TM, Stadius ML. Coronary artery vasoconstriction routinely occurs after percutaneous transluminal coronary angioplasty: a quantitative arteriographic analysis. Circulation. 1988;78:1323-1334.
30. Rensing BJ, Hermans WRM, Beatt KJ, Laarman GJ, Suryapranata H, van den Brand M, de Feyter PJ, Serruys PW. Quantitative angiographic assessment of elastic recoil after percutaneous transluminal coronary angioplasty. Am J Cardiol. 1990;66:1039-1044.
31. Miyamoto A, Friedl SE, Lin FC, Nesto RW, Abela GS. Plaque cap thickness can be detected by quantitative color analysis of angioscopic images in a plaque model. In: Anderson R, ed. Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems V. Bellingham, WA: Proceedings/SPIE - The International Society for Optical Engineering; May 1995;2395:429.
32. Fernandez-Ortiz A, Badimon JJ, Falk E, Fuster V, Meyer B, Mailhac A, Weng D, Shah PK, Badimon L. Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J Am Coll Cardiol. 1994;23:1562-1569.
33. Wilcox JN, Smith KM, Schwartz SM, Gordon D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA. 1989;86:2839-2843.
34. Annex BH, Denning SM, Channon KM, Sketch MH Jr, Stack RS, Morrisey JH, Peters KG. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation. 1995;91: 619-622.
35. Pawashe AB, Golino P, Ambrosio G, Migliaccio F, Ragni M, Pascucci I, Chiariello M, Bach R, Garen A, Konigsbert WK, Ezekowitz MD. A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries. Circ Res. 1994;74:56-63.
36. Rasheed O, Hodgson JM. Application of intracoronary ultrasonography in the study of coronary artery pathophysiology. J Clin Ultrasound. 1993;21:569-578.
37. De Franco AC, Nissen SE, Murat TE, Lefkovits J, Molitcrno DJ, Guyer S, Ellis SG. Ultrasound plaque morphology predicts major dissections following stand-alone and adjunctive balloon angioplasty. Circulation. 1994;90(part 2):I-59. Abstract.
38. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty: the EPIC investigation. N Engl J Med. 1994;330: 956-961.
39. Lukas MA, Deutsch E, Barnathan E, Laskey WK. Influence of heparin therapy on percutaneous transluminal coronary angioplasty outcome in patients with coronary arterial thrombus. Am J Cardiol. 1990;65:179-182.
40. Douglas JS Jr, Lutz JF, Clements SD, Robinson PH, Roubin GS, Lembo NJ, King SB III. Therapy of large intracoronary thrombi in candidates for percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 1988;11:238A. Abstract.
41. Schieman G, Cohen BM, Kozina J, Erickson JS, Podolin RA, Peterson KL, Ross J Jr, Buchbinder M. Intracoronary urokinase for intracoronary thrombus accumulation complicating percutaneous transluminal coronary angioplasty in acute ischemic syndromes. Circulation. 1990;82:2052-2060.
42. Topol EJ, Bonan R, Jewitt D, Sigwart U, Kakkar VV, Rothman M, de Bono D, Ferguson J, Willerson JT, Strony J, Ganz P, Cohen MD, Raymond R, Fox I, Maraganore J, Adelman B. Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty. Circulation. 1993;87:1622-1629.
43. Mitchel JF, Azrin MA, Fram DB, Hong MK, Wong SC, Barry JJ, Bow LM, Curley TM, Kiernan FJ, Waters DD. Inhibition of platelet deposition and lysis of intracoronary thrombus during balloon angioplasty using urokinase-coated hydrogel balloons. Circulation. 1994;90:1979-1988.
44. Siegel RJ, Gunn J, Ahsan A, Fishbein MC, Bowes RJ, Oakley D, Wales C, Steffen W, Campbell S, Nita H, Mills T, Silverton P, Myler RK, Cumberland DC. Use of therapeutic ultrasound in percutaneous coronary angioplasty: experimental in vitro studies and initial clinical experience. Circulation. 1994;89:1587-1593.
45. Popma JJ, Leon MB, Mintz GS, Kent KM, Satler LF, Garrand TJ, Pichard AD. Results of coronary angioplasty using the transluminal extraction catheter. Am J Cardiol. 1992;70:1526-1532.
46. White CJ, Ramee SR, Collins TJ, Jain SP, Escobar A, Soni D, Bass TA, Heuser RR, Teirstein PS, Bonan R, Nesto RW, Walter PD, Smalling RW, Knopf WD. Angioscopically detected coronary thrombus correlates with adverse PTCA outcome. Circulation. 1993;88(pt 2):I-596. Abstract.
47. Golino P, Ashton JH, Glass-Greenwalt P, McNatt J, Buja LM, Willerson JT. Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis. Circulation. 1988; 77:678-684.
48. Fitzgerald DJ, Catella F, Roy L, Fitzgerald GA. Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction. Circulation. 1988;77:142-150.
49. Meyer BJ, Badimon JJ, Mailhac A, Fernandez-Ortiz A, Chesebro JH, Fuster V, Badimon L. Inhibition of growth of thrombus on fresh mural thrombus: targeting optimal therapy. Circulation. 1994; 90:2432-2438.
50. Tan K, Sulke N, Taub N, Sowton E. Clinical and lesion morphologic determinants of coronary angioplasty success and complications: current experience. J Am Coll Cardiol. 1995;25:855-865.
51. Dorros G, Cowley MJ, Simpson J, Bentivoglio LG, Block PC, Bourassa M, Detre K, Gosselin AJ, Gruntzig AR, Kelsey SF, Kent KM, Mock MB, Mullin SM, Myler RK, Passamani ER, Stertzer SH, Williams DO. Percutaneous transluminal coronary angioplasty: report of complications from the National Heart, Lung, and Blood Institute PTCA Registry. Circulation. 1983;67:723-730.
52. Bentivoglio LG, Detre K, Yen W, Williams DO, Kelsey SF, Faxon DP. Outcome of percutaneous transluminal coronary angioplasty in subsets of unstable angina pectoris: a report of the 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. J Am Coll Cardiol. 1994;24: 1195-1206.
53. Abdelmeguid AE, Ellis SG, Sapp SK, Simpfendorfer C, Franco I, Whitlow PL. Directional coronary atherectomy in unstable angina. J Am Coll Cardiol. 1994;24:46-54.
54. Itoh A, Miyazaki S, Nonogi H, Daikoku S, Haze K. Angioscopic prediction of successful dilatation and of restenosis in percutaneous transluminal coronary angioplasty. Circulation. 1995;91:1389-1396.
55. de Feyter PJ, Serruys PW, van den Brand M, Hughenholtz PG. Percutaneous transluminal coronary angioplasty for unstable angina. Am J Cardiol. 1991;68(suppl):125B-135B.
56. Mizuno K, Miyamoto A, Satomura K, Kurita A, Arai T, Sakurada M, Yanagida S, Nakamura H. Angioscopic coronary macromorphology in patients with acute coronary disorders. Lancet. 1991;337: 809-812.
57. Flugelman MY, Virmani R, Correa R, Yu ZX, Farb A, Leon MB, Elami A, Fu YM, Casscells W, Epstein SE. Smooth muscle cell abundance and fibroblast growth factors in coronary lesions of patients with nonfatal unstable angina: a clue to the mechanism of transformation from the stable to the unstable clinical state. Circulation. 1993;88:2493-2500.
58. White CJ, Ramee SR, Mesa JE, Collins TJ. Percutaneous coronary angioscopy in patients with restenosis after coronary angioplasty. J Am Coll Cardiol. 1991;17:46B-49B.